Energy -
Oil & Gas Midstream - NYSE - BM
$ 16.05
4.83 %
$ 3.57 B
Market Cap
6.52
P/E
1. INTRINSIC VALUE
Balance Sheet
Frontline Ltd.
| Current Assets | 728 M |
| Cash & Short-Term Investments | 316 M |
| Receivables | 144 M |
| Other Current Assets | 268 M |
| Non-Current Assets | 5.15 B |
| Long-Term Investments | 51.5 M |
| PP&E | 4.64 B |
| Other Non-Current Assets | 468 M |
| Current Liabilities | 409 M |
| Accounts Payable | 7.8 M |
| Short-Term Debt | 263 M |
| Other Current Liabilities | 138 M |
| Non-Current Liabilities | 3.2 B |
| Long-Term Debt | 3.2 B |
| Other Non-Current Liabilities | 472 K |
EFFICIENCY
Earnings Waterfall
Frontline Ltd.
| Revenue | 1.8 B |
| Cost Of Revenue | 1.03 B |
| Gross Profit | 776 M |
| Operating Expenses | 29.4 M |
| Operating Income | 747 M |
| Other Expenses | 90.3 M |
| Net Income | 656 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Frontline Ltd.
| Net Income | 656 M |
| Depreciation & Amortization | 231 M |
| Capital Expenditures | -1.63 B |
| Stock-Based Compensation | 10.7 M |
| Change in Working Capital | -8.51 M |
| Others | -39.5 M |
| Free Cash Flow | -775 M |
Wall Street Analysts Price Targets
Frontline Ltd.
Wall Street analysts predict an average 1-year price target for FRO of $28.3 , with forecasts ranging from
a
low of
$25 to a high of $30 .
FRO Lowest Price Target
Wall Street Target
25 USD
55.76%
FRO Average Price Target
Wall Street Target
28.3 USD
76.53%
FRO Highest Price Target
Wall Street Target
30 USD
86.92%
4. DIVIDEND
ANALYSIS
2.71%
DIVIDEND YIELD
0.34 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Frontline Ltd.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|
7. News
Jefferies Loves 3 Very Large Crude Carriers That Pay Ultra-High-Yield Dividends Up to 12%
Investors love dividend stocks, especially the ultra-high-yield variety because they offer a significant income stream and have massive total return potential.
247wallst.com
- 1 week ago
Aptose Announces Positive Clinical Safety Review Committee (CSRC) Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib Amid Complete Responses and Favorable Safety in First Cohort
Aptose Announces Positive Clinical Safety Review and Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib
globenewswire.com
- 1 week ago
10 Ideal 'Safer' January Dividend Buys, Out Of 40 Choices From Readers
Before January 31, 2025, my REaders mentioned 40 equities in their comments on my articles. Some bad-news investments (ROgues) mixed with (mostly) FAvorites. Thus, readers spoke-up about the ReFa/Ro. Ten analyst-target-estimated TOP-NET-GAIN ReFa/Ro: CAG, VZ, DOW, PFE, MRK GOGL, PK, PBR FRO, and TRMD averaged 40.36% net gains from reader data collected 2/17/25. Ten analysts target-augured January TOP-PRICE-UPSIDE reader faves & rogues (ReFa/Ro) were: CAG, VZ, PBR, DOW, PFE, GOGL, TRMD, PK, MRK, & FRO, boasting a 27.91% average target price upside estimate.
seekingalpha.com
- 1 week ago
Aptose's Frontline Triple Drug Therapy with Tuspetinib Achieves Notable Responses in Newly Diagnosed AML Patients in the Phase 1/2 TUSCANY Trial
TUS+VEN+AZA triplet achieves Cycle 1 complete remission (CR) in TP53-mutated/CK AML TUS+VEN+AZA triplet achieves Cycle 1 complete remissions in FLT3-wildtype AML patients TUS+VEN+AZA triplet shows favorable safety with no alteration of VEN and AZA dosing PK levels of TUS in the triplet remain equivalent to levels as TUS or TUS+VEN therapy SAN DIEGO and TORONTO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company, today reported promising early safety and response results from newly diagnosed acute myeloid leukemia (AML) patients dosed in Aptose's Phase 1/2 TUSCANY trial with a 40 mg dose of tuspetinib in combination with standard of care dosing of venetoclax and azacitidine (TUS+VEN+AZA triplet). The TUS+VEN+AZA triplet is being developed as a frontline therapy to treat large, mutationally diverse populations of newly diagnosed AML patients who are ineligible to receive induction chemotherapy.
globenewswire.com
- 2 weeks ago
4 Contrarian Ultra-High-Yield Stocks Pay Huge Passive Income Dividends as High as 15%
Passive income is characterized by its ability to generate revenue without requiring continuous active effort from the earner.
247wallst.com
- 1 month ago
Verizon Frontline delivering 5G connectivity to New York State Police cruisers
ALBANY, N.Y., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Verizon Frontline today announced it will provide 5G connectivity across the New York State Police's fleet of vehicles through the activation of more than 1,800 lines of service.
globenewswire.com
- 1 month ago
Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY Trial
SAN DIEGO and TORONTO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company, today announced dosing the first set of patients in the TUSCANY Phase 1/2 study with tuspetinib (TUS) in combination with venetoclax (VEN) and azacitidine (AZA) as a frontline triple drug combination (triplet) therapy for patients newly diagnosed with acute myeloid leukemia, or AML. Tuspetinib based TUS+VEN+AZA triplet therapy is being advanced in the TUSCANY Phase 1/2 trial with the goal of creating an improved frontline therapy for newly diagnosed AML patients that is active across diverse AML populations, durable, and well tolerated.
globenewswire.com
- 1 month ago
New Body Camera by Motorola Solutions Boosts Safety for Frontline Workers
CHICAGO--(BUSINESS WIRE)--Motorola Solutions (NYSE: MSI) today unveiled the V200, a body camera designed specifically to help protect frontline workers in stores, hospitals, hotels, schools and stadiums. Workers in these settings regularly face safety concerns – from unwelcome behavior to theft and medical emergencies – and the V200, with its GoLive Audio safety feature, offers a direct connection to help. The V200 body camera is a discreet, lightweight addition to a worker's uniform. The recor.
businesswire.com
- 1 month ago
4 Of 35 Safe-Buy Dividend Power Dogs In January
Four low-priced Dividend Power stocks, Golden Ocean, Invesco Mortgage, ARMOUR Residential, and FutureFuel, offer safer dividends with free cash-flow yields exceeding dividend yields. The Dividend Power strategy focuses on high earnings yield and top dividend yield stocks, creating a resilient portfolio for both downturns and bull markets. Analysts project significant gains for top Dividend Power stocks, with an average net gain of 79.97% on $10k invested in the top ten.
seekingalpha.com
- 1 month ago
Verizon Frontline showcases advanced communications solutions at EDGE25
The EDGE25 keynote will be delivered by Verizon Frontline and the U.S. Secret Service The EDGE25 keynote will be delivered by Verizon Frontline and the U.S. Secret Service
globenewswire.com
- 1 month ago
Is the Options Market Predicting a Spike in Frontline (FRO) Stock?
Investors need to pay close attention to Frontline (FRO) stock based on the movements in the options market lately.
zacks.com
- 2 months ago
5 Ultra-High-Yield Dividend Stocks for 2025 Wall Street Is Pounding the Table On
Dividend stocks are a favorite among investors for good reason. They provide a steady income stream of passive income and offer a promising avenue for total return.
247wallst.com
- 2 months ago
8. Profile
Summary
Frontline Ltd. FRO
COUNTRY
BM
INDUSTRY
Oil & Gas Midstream
MARKET CAP
$ 3.57 B
Dividend Yield
2.71%
Description
Frontline Ltd., a shipping company, engages in the seaborne transportation of crude oil and oil products worldwide. It owns and operates oil and product tankers. As of December 31, 2021, the company operated a fleet of 70 vessels. It is also involved in the charter, purchase, and sale of vessels. The company was founded in 1985 and is based in Hamilton, Bermuda.
Contact
Par-la-Ville Place, Hamilton, HM 08
https://www.frontline.bm
IPO
Date
Aug. 6, 2001
Employees
88
Officers
Marios Saveriades
Secretary
Mr. Lars H. Barstad
Chief Executive Officer of Frontline Management AS
Ms. Inger Marie Klemp
Chief Financial Officer of Frontline Management AS